MENU
ADAG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Adagene (ADAG) Ownership - Who owns Adagene?
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies... Show more
Profile
Industry
N/A
Address
Xinghu Street, Suzhou Industrial Park
Phone
+86 51287773632
Employees
174
Web
https://www.adagene.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
102.23M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
ADAG
Capitalization
102M
P/E Ratio
N/A
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
2.02
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
11.6M
Shares Outstanding - Current
47.1M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
9.045
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ADAG showed earnings on March 24, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Xinghu Street, Suzhou Industrial Park
Phone
+86 51287773632
Employees
174
Web
https://www.adagene.com